Van ECK Associates Corp Takes Position in American Healthcare REIT, Inc. (NYSE:AHR)

Van ECK Associates Corp bought a new position in shares of American Healthcare REIT, Inc. (NYSE:AHR) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 14,148 shares of the company’s stock, valued at approximately $363,000.

Several other hedge funds have also recently bought and sold shares of AHR. Mirae Asset Global Investments Co. Ltd. increased its position in shares of American Healthcare REIT by 34.7% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,537 shares of the company’s stock worth $66,000 after acquiring an additional 654 shares in the last quarter. Kozak & Associates Inc. purchased a new stake in American Healthcare REIT during the 3rd quarter worth $28,000. Kessler Investment Group LLC acquired a new stake in American Healthcare REIT in the 3rd quarter valued at $48,000. Kiely Wealth Advisory Group Inc. acquired a new stake in American Healthcare REIT in the 2nd quarter valued at $30,000. Finally, Creekmur Asset Management LLC purchased a new position in American Healthcare REIT in the third quarter valued at about $54,000. Hedge funds and other institutional investors own 16.68% of the company’s stock.

American Healthcare REIT Stock Performance

AHR opened at $25.95 on Wednesday. The company has a 50-day moving average of $24.96 and a 200-day moving average of $19.07. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.29 and a quick ratio of 0.29. American Healthcare REIT, Inc. has a 1-year low of $12.63 and a 1-year high of $27.21.

American Healthcare REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 18th. Shareholders of record on Friday, September 20th were paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 3.85%. The ex-dividend date was Friday, September 20th.

Analysts Set New Price Targets

A number of research firms have recently issued reports on AHR. Colliers Securities upgraded American Healthcare REIT from a “hold” rating to a “moderate buy” rating in a research note on Sunday, October 13th. Bank of America lifted their price objective on shares of American Healthcare REIT from $27.00 to $31.00 and gave the company a “buy” rating in a research note on Tuesday, September 24th. Morgan Stanley upped their target price on shares of American Healthcare REIT from $17.00 to $22.00 and gave the company an “overweight” rating in a research note on Thursday, August 22nd. JMP Securities lifted their price target on shares of American Healthcare REIT from $18.00 to $30.00 and gave the stock a “market outperform” rating in a research note on Friday, September 20th. Finally, KeyCorp upped their price objective on shares of American Healthcare REIT from $16.00 to $27.00 and gave the company an “overweight” rating in a research report on Monday, September 16th. One research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $23.00.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.